Notice Information
Notice Title
NHS National Pharmaceuticals Dasatinib and Paliperidone Injection
Notice Description
Proposed framework agreement for NHS National Generic Pharmaceuticals Dasatinib and Paliperidone Injection. Offer reference number: CM/PHG/22/5694<br/><br/><br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/22/5694/00 - Dasatinib <br/>CESW 01/05/2023 - 30/04/2024 - (12 Months) <br/>LSNE 01/05/2023 - 30/04/2024 - (12 Months)<br/>NWLN 01/05/2023 - 30/04/2024 - (12 Months)<br/><br/>CM/PHG/22/5694/01 - Paliperidone Injection: <br/>LSNE 01/05/2023 - 31/05/2024 (13 Months) <br/>NWLN 01/05/2023 - 31/01/2025 (21 months)
Lot Information
5. Lot 2 CM/PHG/22/5694/01 Supplier offer confirmation (check box)
Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
CM/PHG/22/5694/00 - Dasatinib
CESW - 01/05/2023 - 30/04/2024 - (12 Months)
LSNE - 01/05/2023 - 30/04/2024 - (12 Months)
NWLN - 01/05/2023 - 30/04/2024 - (12 Months)
CM/PHG/22/5694/01 - Paliperidone Injection:
LSNE - 01/05/2023 - 31/05/2024 (13 Months)
NWLN - 01/05/2023 - 31/01/2025 (21 months)
Options: Options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
4. Lot 1 CM/PHG/22/5694/00 Supplier offer confirmation (check box)Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
CM/PHG/22/5694/00 - Dasatinib
CESW - 01/05/2023 - 30/04/2024 - (12 Months)
LSNE - 01/05/2023 - 30/04/2024 - (12 Months)
NWLN - 01/05/2023 - 30/04/2024 - (12 Months)
CM/PHG/22/5694/01 - Paliperidone Injection:
LSNE - 01/05/2023 - 31/05/2024 (13 Months)
NWLN - 01/05/2023 - 31/01/2025 (21 months)
Options: Option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-03981f
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/012161-2023
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £108,792,862 £100M-£1B
- Lots Value
- £60,373,911 £10M-£100M
- Awards Value
- Not specified
- Contracts Value
- £1
Notice Dates
- Publication Date
- 27 Apr 20232 years ago
- Submission Deadline
- 21 Feb 2023Expired
- Future Notice Date
- Not specified
- Award Date
- 21 Feb 20233 years ago
- Contract Period
- 30 Apr 2023 - 30 Apr 2024 1-2 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ENGLAND
- Contact Name
- Sharron Giblin
- Contact Email
- sharron.giblin@nhs.net
- Contact Phone
- Not specified
Buyer Location
- Locality
- LEEDS
- Postcode
- LS2 7UE
- Post Town
- Leeds
- Country
- England
-
- Major Region (ITL 1)
- TLE Yorkshire and The Humber
- Basic Region (ITL 2)
- TLE4 West Yorkshire
- Small Region (ITL 3)
- TLE42 Leeds
- Delivery Location
- Not specified
-
- Local Authority
- Leeds
- Electoral Ward
- Little London & Woodhouse
- Westminster Constituency
- Leeds Central and Headingley
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-03981f-2023-04-27T14:59:02+01:00",
"date": "2023-04-27T14:59:02+01:00",
"ocid": "ocds-h6vhtk-03981f",
"description": "RESPONDING TO THIS NOTICE;<br/>Any supplier may be disqualified who does not respond to the following in the requisite manner:<br/>1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.uk<br/>Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows:<br/>1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register:<br/>- agree to the user agreement<br/>- populate company details<br/>1.2) Once registered, candidates must register interest as follows:<br/>- log to the portal<br/>- select \"Find Opportunities\" from the supplier home screen, use the \"Sort by:\" facility to find this opportunity and select the bold blue title to select<br/>- review opportunity details and click \"Register Interest\"<br/>- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity)<br/>1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at supporthealth@atamis.co.uk or by calling 0800 9956035 for technical assistance when completing responses.<br/>2) General supplier information.<br/>To manage and assess supplier information the Contracting Authority requests candidates provide their<br/>company profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:<br/>2.1) If not already registered (the previous sid4gov password, login and details will still<br/>be on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk<br/>and select \"Register\" at the top of the page.<br/>Key in details as requested to search for your company. If you do not have a D-U-N-S(r) Number, click on the link at the right of the page to obtain a number from D&B.<br/>Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S(r) Number to enable registration on the system.<br/>2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.<br/>D&B data will be supplied automatically by D&B.<br/>2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via the<br/>message function on the website.<br/>OTHER CONTRACTING AUTHORITIES<br/>The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.",
"initiationType": "tender",
"tender": {
"id": "CM/PHG/22/5694",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NHS National Pharmaceuticals Dasatinib and Paliperidone Injection",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
"mainProcurementCategory": "goods",
"description": "Proposed framework agreement for NHS National Generic Pharmaceuticals Dasatinib and Paliperidone Injection. Offer reference number: CM/PHG/22/5694<br/><br/><br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/22/5694/00 - Dasatinib <br/>CESW 01/05/2023 - 30/04/2024 - (12 Months) <br/>LSNE 01/05/2023 - 30/04/2024 - (12 Months)<br/>NWLN 01/05/2023 - 30/04/2024 - (12 Months)<br/><br/>CM/PHG/22/5694/01 - Paliperidone Injection: <br/>LSNE 01/05/2023 - 31/05/2024 (13 Months) <br/>NWLN 01/05/2023 - 31/01/2025 (21 months)",
"value": {
"amount": 108792862,
"currency": "GBP"
},
"lots": [
{
"id": "2",
"title": "5. Lot 2 CM/PHG/22/5694/01 Supplier offer confirmation (check box)",
"description": "Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection<br/><br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/PHG/22/5694/00 - Dasatinib<br/>CESW - 01/05/2023 - 30/04/2024 - (12 Months)<br/>LSNE - 01/05/2023 - 30/04/2024 - (12 Months)<br/>NWLN - 01/05/2023 - 30/04/2024 - (12 Months)<br/><br/>CM/PHG/22/5694/01 - Paliperidone Injection:<br/>LSNE - 01/05/2023 - 31/05/2024 (13 Months)<br/>NWLN - 01/05/2023 - 31/01/2025 (21 months)",
"value": {
"amount": 44234260,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2023-05-01T00:00:00+01:00",
"endDate": "2025-01-31T23:59:59Z"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months."
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
},
{
"id": "1",
"title": "4. Lot 1 CM/PHG/22/5694/00 Supplier offer confirmation (check box)",
"description": "Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection<br/><br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. <br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/PHG/22/5694/00 - Dasatinib <br/>CESW - 01/05/2023 - 30/04/2024 - (12 Months) <br/>LSNE - 01/05/2023 - 30/04/2024 - (12 Months)<br/>NWLN - 01/05/2023 - 30/04/2024 - (12 Months)<br/><br/>CM/PHG/22/5694/01 - Paliperidone Injection: <br/>LSNE - 01/05/2023 - 31/05/2024 (13 Months) <br/>NWLN - 01/05/2023 - 31/01/2025 (21 months)",
"value": {
"amount": 16139651,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2023-05-01T00:00:00+01:00",
"endDate": "2024-04-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
}
}
],
"items": [
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "NHS England"
},
"relatedLot": "2"
},
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "NHS England"
},
"relatedLot": "1"
}
],
"submissionMethod": [
"electronicSubmission",
"written"
],
"submissionMethodDetails": "https://health-family.force.com/s/Welcome",
"communication": {
"atypicalToolUrl": "https://health-family.force.com/s/Welcome"
},
"documents": [
{
"id": "economic",
"documentType": "economicSelectionCriteria"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"techniques": {
"hasFrameworkAgreement": true
},
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2023-02-21T13:00:00Z"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"awardPeriod": {
"startDate": "2023-02-21T13:00:00Z"
},
"bidOpening": {
"date": "2023-02-21T13:00:00Z",
"address": {
"streetAddress": "Runcorn"
},
"description": "Commercial Medicines Unit Employee"
},
"hasRecurrence": false,
"contractTerms": {
"hasElectronicOrdering": true,
"hasElectronicPayment": true
}
},
"parties": [
{
"id": "GB-FTS-67205",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "1st Floor, Quarry House, Quarry Hill",
"locality": "Leeds",
"region": "UKE",
"postalCode": "LS2 7UE",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Sharron Giblin",
"email": "sharron.giblin@nhs.net",
"url": "https://health-family.force.com/s/Welcome"
},
"roles": [
"buyer",
"centralPurchasingBody"
],
"details": {
"url": "https://www.england.nhs.uk//",
"buyerProfile": "https://www.england.nhs.uk//",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-1661",
"name": "The High Court",
"identifier": {
"legalName": "The High Court"
},
"address": {
"streetAddress": "The Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
}
},
{
"id": "GB-FTS-81410",
"name": "Zentiva Pharma UK Ltd",
"identifier": {
"legalName": "Zentiva Pharma UK Ltd"
},
"address": {
"locality": "Felstead",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-7494",
"name": "Teva UK Limited",
"identifier": {
"legalName": "Teva UK Limited"
},
"address": {
"locality": "Castleford",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-18488",
"name": "Mylan",
"identifier": {
"legalName": "Mylan"
},
"address": {
"locality": "Hatfield",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-7492",
"name": "Janssen-Cilag Ltd",
"identifier": {
"legalName": "Janssen-Cilag Ltd"
},
"address": {
"locality": "High Wycombe",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-4065",
"name": "Mercury Pharmaceuticals Limited",
"identifier": {
"legalName": "Mercury Pharmaceuticals Limited"
},
"address": {
"locality": "London",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
}
],
"buyer": {
"id": "GB-FTS-67205",
"name": "NHS England"
},
"language": "en",
"awards": [
{
"id": "012161-2023-1",
"title": "Lot 1-CM/PHG/22/5694/00",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-81410",
"name": "Zentiva Pharma UK Ltd"
}
]
},
{
"id": "012161-2023-2",
"title": "Lot 1-CM/PHG/22/5694/00",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7494",
"name": "Teva UK Limited"
}
]
},
{
"id": "012161-2023-3",
"title": "Lot 1-CM/PHG/22/5694/00",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-18488",
"name": "Mylan"
}
]
},
{
"id": "012161-2023-4",
"title": "CM/PHG/22/5695/01",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7492",
"name": "Janssen-Cilag Ltd"
}
]
},
{
"id": "012161-2023-5",
"title": "CM/PHG/22/5695/01",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7494",
"name": "Teva UK Limited"
}
]
},
{
"id": "012161-2023-6",
"title": "CM/PHG/22/5695/01",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4065",
"name": "Mercury Pharmaceuticals Limited"
}
]
}
],
"contracts": [
{
"id": "012161-2023-1",
"awardID": "012161-2023-1",
"title": "Lot 1-CM/PHG/22/5694/00",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2023-02-21T00:00:00Z"
},
{
"id": "012161-2023-2",
"awardID": "012161-2023-2",
"title": "Lot 1-CM/PHG/22/5694/00",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2023-02-21T00:00:00Z"
},
{
"id": "012161-2023-3",
"awardID": "012161-2023-3",
"title": "Lot 1-CM/PHG/22/5694/00",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2023-02-21T00:00:00Z"
},
{
"id": "012161-2023-4",
"awardID": "012161-2023-4",
"title": "CM/PHG/22/5695/01",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2023-02-21T00:00:00Z"
},
{
"id": "012161-2023-5",
"awardID": "012161-2023-5",
"title": "CM/PHG/22/5695/01",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2023-02-21T00:00:00Z"
},
{
"id": "012161-2023-6",
"awardID": "012161-2023-6",
"title": "CM/PHG/22/5695/01",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2023-02-21T00:00:00Z"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"value": 5
},
{
"id": "3",
"measure": "bids",
"value": 5
},
{
"id": "5",
"measure": "bids",
"value": 5
},
{
"id": "7",
"measure": "bids",
"value": 5
},
{
"id": "9",
"measure": "bids",
"value": 5
},
{
"id": "11",
"measure": "bids",
"value": 5
},
{
"id": "2",
"measure": "electronicBids",
"value": 5
},
{
"id": "4",
"measure": "electronicBids",
"value": 5
},
{
"id": "6",
"measure": "electronicBids",
"value": 5
},
{
"id": "8",
"measure": "electronicBids",
"value": 5
},
{
"id": "10",
"measure": "electronicBids",
"value": 5
},
{
"id": "12",
"measure": "electronicBids",
"value": 5
}
]
}
}